Table of Contents

1.       Research Methodology

2.       Project Scope & Definitions

3.       Impact of COVID-19 on Japan AI in Medical Diagnostics Market

4.       Executive Summary

5.       Japan AI in Medical Diagnosis Market Outlook, FY2017-FY2031F

5.1.    Market Size & Forecast

5.1.1.By Value

5.1.2.By Volume

5.2.    By Component Type

5.2.1.Software

5.2.2.Hardware

5.2.3.Services

5.3.    By Diagnosis Type

5.3.1.In-Vitro Diagnostics

5.3.2.Diagnostic Imaging

5.3.2.1.              X-rays

5.3.2.2.              CT Scan

5.3.2.3.              MRI

5.3.2.4.              Ultrasound

5.3.2.5.              Others

5.3.3.Others

5.4.    By Application

5.4.1.Oncology

5.4.2.Neurology

5.4.3.Cardiology

5.4.4.Radiology

5.4.5.Pulmonology

5.4.6.Obstetrics/Gynaecology

5.4.7.Others

5.5.    By Technology

5.5.1.Natural Language Processing

5.5.2.Machine Learning

5.5.3.Context-Aware Computing

5.5.4.Computer Vision

5.6.    By End-user

5.6.1.Hospitals

5.6.2.Diagnostic Imaging Centers

5.6.3.Diagnostic Laboratories

5.6.4.Others

5.7.    By Region

5.7.1.North - Hokkaido and Tohoku

5.7.2.Central - Kanto and Chubu

5.7.3.South - Kansai, Chugoku, Shikoku, and Kyushu & Okinawa

5.6   By Company Market Share (%), FY2023

6.       Market Mapping, FY2023

6.1.      By Component Type

6.2.      By Diagnosis Type

6.3.      By Application

6.4.      By Technology

6.5.      By End-user

6.6.      By Region

7.       Macro Environment and Industry Structure

7.1.      Supply Demand Analysis

7.2.      Import Export Analysis – Volume and Value

7.3.      Supply/Value Chain Analysis

7.4.      PESTEL Analysis

7.4.1.Political Factors

7.4.2.Economic System

7.4.3.Social Implications

7.4.4.Technological Advancements

7.4.5.Environmental Impacts

7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)

7.5.      Porter’s Five Forces Analysis

7.5.1.Supplier Power

7.5.2.Buyer Power

7.5.3.Substitution Threat

7.5.4.Threat from New Entrant

7.5.5.Competitive Rivalry

8.       Market Dynamics

8.1.    Growth Drivers

8.2.    Growth Inhibitors (Challenges, Restraints)

9.       Regulatory Framework and Innovation

9.1.    Patent Landscape

9.2.    Regulatory Approvals

9.3.    Innovations/Emerging Technologies

10.   Key Players Landscape

10.1.  Competition Matrix of Top Five Market Leaders

10.2.  Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)

10.3.  Mergers and Acquisitions/Joint Ventures (If Applicable)

10.4.  SWOT Analysis (For Five Market Players)

10.5.  Patent Analysis (If Applicable)

11.   Pricing Analysis

12.   Case Studies

13.   Key Players Outlook

13.1.                     Fujifilm Holdings Corporation

13.1.1.    Company Details

13.1.2.    Key Management Personnel

13.1.3.    Products & Services

13.1.4.    Financials (As reported)

13.1.5.    Key Market Focus & Geographical Presence

13.1.6.    Recent Developments

13.2.                     Toshiba Corporation

13.3.                     Hitachi Ltd

13.4.                     IBM Watson Health

13.5.                     Siemens Healthineers

13.6.                     Philips Healthcare

13.7.                     GE Healthcare

13.8.                     Google Health

13.9.                     NEC Corporation

13.10.                  Sysmex Corporation

14.   Strategic Recommendations

15.   About Us & Disclaimer